Apremilast

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

HPP737 in Adult Patients With Plaque Psoriasis

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease

Comparative Efficacy of Apremilast and Acitretin in Moderate-to-Severe Hidradenitis Suppurativa

A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Apremilast for Erythema Multiforme

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Methotrexate Versus Apremilast for Pruritus in Psoriasis

Human Laboratory Study of Apremilast for Alcohol Use Disorder

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis

Apremilast and Adalimumab in Psoriatic Arthritis Patients

Apremilast for Alcohol Use Disorder Treatment in Women and Men

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis